MML Investors Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,784
| Closed | -$400K | – | 2829 |
|
|
2024
Q4 | $400K | Buy |
4,784
+787
| +20% | +$65.8K | ﹤0.01% | 2065 |
|
|
2024
Q3 | $292K | Sell |
3,997
-133
| -3% | -$9.72K | ﹤0.01% | 2201 |
|
|
2024
Q2 | $283K | Sell |
4,130
-5,499
| -57% | -$377K | ﹤0.01% | 2122 |
|
|
2024
Q1 | $666K | Buy |
9,629
+2,321
| +32% | +$161K | ﹤0.01% | 1641 |
|
|
2023
Q4 | $523K | Sell |
7,308
-1,937
| -21% | -$139K | ﹤0.01% | 1728 |
|
|
2023
Q3 | $482K | Buy |
9,245
+5,603
| +154% | +$292K | ﹤0.01% | 1658 |
|
|
2023
Q2 | $231K | Sell |
3,642
-1,117
| -23% | -$70.8K | ﹤0.01% | 2088 |
|
|
2023
Q1 | $258K | Buy |
4,759
+833
| +21% | +$45.2K | ﹤0.01% | 1772 |
|
|
2022
Q4 | $208K | Buy |
+3,926
| New | +$208K | ﹤0.01% | 2009 |
|
|
2021
Q1 | – | Sell |
-9,570
| Closed | -$304K | – | 1846 |
|
|
2020
Q4 | $304K | Buy |
+9,570
| New | +$304K | ﹤0.01% | 1386 |
|
|
2020
Q3 | – | Sell |
-31,200
| Closed | -$801K | – | 1619 |
|
|
2020
Q2 | $801K | Buy |
+31,200
| New | +$801K | 0.01% | 798 |
|